NUTX Nutex Health Inc.

$200.24▲ +2.58% Healthcare Other
After hours $200.24▲ +0.00% Sep 11, 7:30 PM ET
Volume 137.0K Avg Volume (10D) 153.8K
Key Metrics & Fundamentals
Market Cap
$1.37B
P/E Ratio
7.8
Div Yield
–%
52W Range
83.99 - 204.00
% vs 50 MA
13.29%
% vs 200 MA
40.43%
RSI-14
61.6
MACD Histogram
-0.1800
Beta (1Y vs SPY)
2.08
Free Cash Flow
$31.66M
Gross Rev
$210.75M
Gross Profit
$141.28M
EBITDA
$127.07M
COGS
$69.47M
Operating Exp
$19.56M
Operating Income
$121.72M
EBIT
$121.72M
Pretax Income
$117.09M
Net Income
$65.84M
EPS (Diluted)
9.38
Price & Volume History
Loading chart…
Recent News
Stock Market Leaders Often Shine, Helped By This Sign Of Liquidity Strength
Investor's Business Daily · Sep 11, 2026 2:28 PM
Sector Update: Healthcare Stocks Flat to Higher Premarket Friday
MT Newswires · Sep 11, 2026 1:16 PM
What Makes Nutex Health (NUTX) a Good Fit for 'Trend Investing'
Zacks · Sep 11, 2026 12:55 PM
Nutex Health Says Cybersecurity Incident Data Published Online
MT Newswires · Sep 11, 2026 10:50 AM
NUTEX HEALTH PROVIDES UPDATE REGARDING CYBERSECURITY EVENT
PR Newswire · Sep 10, 2026 11:00 PM
B. Riley Adjusts Price Target on Nutex Health to $325 From $290, Maintains Buy Rating
MT Newswires · Sep 4, 2026 12:13 PM
OpenAI’s Astra Model Can Hack With Minimal Human Help
The Wall Street Journal · Sep 2, 2026 11:32 AM
Nutex Health Says Data Exfiltrated; Faces Class Action Over Cybersecurity Incident
MT Newswires · Aug 31, 2026 9:58 PM
Nutex Health Inc. (NUTX) is a Great Momentum Stock: Should You Buy?
Zacks · Aug 31, 2026 4:00 PM
Nutex Health Hospitals Earn Multiple Community Honors in Second Quarter 2026
PR Newswire · Aug 31, 2026 9:30 AM
Financial Overview - Income Statement Quarterly

See NUTX's money flow as a full page

Social Sentiment
Avg +0.60 · 2 posts
DDNewsPriceTargetNUTX
r/wallstreetbets · Aug 14, 2025
The post presents a positive assessment of the stock with favorable metrics and analyst ratings.
positive +0.60
DDPriceTargetDiscussionNutex Health Inx (NUTX) 10x upside from here
r/wallstreetbets · Aug 4, 2025
The author expresses a bullish outlook (10x upside) and focuses on the company's metrics. However, there's also negative sentiment due to the 'degenerate' nature and poor execution.
positive +0.60
AI Analysis

Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.

Not financial advice. All data, scores, charts, and analysis on this site are provided for informational and educational purposes only and do not constitute financial, investment, legal, or tax advice. Past performance is not indicative of future results. See our Legal Notice for full details.
An unhandled error has occurred. Reload 🗙